RankingsPricing
  1. US-listed companies
  2. CATALYST PHARMACEUTICALS, INC.
  3. Financials
  4. Cash from operations

CATALYST PHARMACEUTICALS, INC.CPRX

Market cap
$2.9B
P/E ratio
SummaryFinancials
Period EndCash from operations (Million USD)YoY (%)
Dec 31, 2024240+67.00%
Dec 31, 2023144+23.74%
Dec 31, 2022116+92.22%
Dec 31, 202160+34.06%
Dec 31, 202045+30.12%
Dec 31, 201935-234.65%
Dec 31, 2018-26+87.04%
Dec 31, 2017-14-23.50%
Dec 31, 2016-18-0.29%
Dec 31, 2015-18+39.20%
Dec 31, 2014-13+31.05%
Dec 31, 2013-10+92.12%
Dec 31, 2012-5+3.12%
Dec 31, 2011-5

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)